DarioHealth Corp. Appoints John R. Palumbo to Board

What Happened DarioHealth Corp. announced that on April 10, 2026 its Board of Directors appointed John R. Palumbo as a director, effective immediately. Mr. Palumbo, age 75, has more than 40 years of healthcare operating experience across early-stage ventures and large enterprises and has served on multiple healthcare and health‑tech boards. The company issued a press release about the appointment on April 13, 2026.

Key Details

• Appointment date: April 10, 2026; press release issued April 13, 2026.
• Experience: 40+ years in healthcare operations; has supported two companies through IPOs and led major operational/commercial transformations.
• Current/Recent boards: PM Pediatrics Management Group (since Aug 2023), Lucid Diagnostics Inc. (NASDAQ: LUCD, since Sept 2025), ivWatch (since May 2025), QLess (since Sept 2025), and chair of Brado Ai’s advisory board (since June 2023).
• Compensation/Disclosure: Mr. Palumbo will receive the same fees as DarioHealth’s other non-executive directors; no arrangements or related‑party transactions requiring additional disclosure were reported.

Why It Matters A new board member with deep healthcare and commercialization experience can influence corporate governance and strategy execution, particularly for a healthcare-focused company like DarioHealth. For investors, this filing signals a governance update rather than a change in executive management or financial results; the company did not report related-party transactions or other material financial impacts in the 8-K.